Los Angeles, CA, United States of America

Jing Huang

This inventor holds 13 USPTO granted patents and 9 published patent applications and 5 EPO patents, primarily in Biotechnology Innovation. Top assignees: University of California, University of Southern California, Chevron U.s.a. Inc.. Active years: 2014-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jing Huang. Retrieved from https://idiyas.com/inventor/jing-huang-2s6a1kgn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13 (Patent Applications = 9)

% Patents Active = 61.5

EPO Patents = 5 (Patent Applications = 11)

Average Co-Inventor Count = 5.4

ph-index = 4

Forward Citations = 71(Granted Patents)

Company Filing History:

8 out of 16,058

University of California

patents

3 out of 1,696

University of Southern California

Cgp Water Systems, LLC

patent

where one patent can have more than one assignee

Years Active: 2014-2024

Loading Chart...

Areas of Expertise:

Artificial Metalloenzyme

Terpenoids

Prodrugs

Glutarate Compounds

Ischemia-Reperfusion

3D Object Recognition

Point Cloud

Ligand Binding

Drug Target Identification

Age-Related Diseases

Multi-View Processing

Flow Compensation

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12129493 - Host cells and methods useful for producing unnatural terpenoids using a novel artificial metalloenzyme (2024-10-29),

2. 11524948 - Prodrugs of alpha-ketoglutarate, alpha-ketobutyrate, alpha-ketoisovalerate, and alpha-ketoisohexanoate, and uses thereof (2022-12-13),

3. 11007163 - Glutarate compounds for treating ischemia-reperfusion injuries (2021-05-18),

4. 10729668 - Ketobutyrate compounds and compositions for treating age-related symptoms and diseases (2020-08-04),

5. 10500177 - Glutarate compounds for treating ischemia-reperfusion injuries (2019-12-10),

6. 10285962 - Glutarate compounds for treating ischemia-reperfusion injuries (2019-05-14),

7. 9619691 - Multi-view 3D object recognition from a point cloud and change detection (2017-04-11),

8. 9610551 - Flow compensator (2017-04-04),

9. 9472022 - Three-dimensional point processing and model generation (2016-10-18),

10. 9358249 - Use of Pateamine A for the treatment of age-related muscle wasting (2016-06-07),

11. 9309103 - Water dispenser system (2016-04-12),

12. 9098773 - System and method of detecting objects in scene point cloud (2015-08-04),

13. 8703438 - Ligand binding stabilization method for drug target identification (2014-04-22),

Title: The Innovative Journey of Inventor Jing Huang

Introduction

Jing Huang, an accomplished inventor based in Los Angeles, CA, has made significant contributions to the field of biotechnology. With a portfolio of 13 patents, Huang's work is focused on developing novel methods and compounds that have the potential to transform various medical treatments and production processes.

Latest Patents

Huang's latest patents reflect his cutting-edge research and innovative approaches. One of his most notable inventions is a method for producing unnatural terpenoids using genetically modified host cells. This invention introduces a novel artificial metalloenzyme that enables these host cells to utilize artificial cofactors, significantly enhancing their production capabilities.

Another leading-edge patent details the creation of prodrugs for compounds such as alpha-ketoglutarate, alpha-ketobutyrate, alpha-ketoisovalerate, and alpha-ketoisohexanoate. These compounds hold promise in the treatment and prevention of age-related diseases and conditions, showcasing Huang's commitment to addressing important health challenges.

Career Highlights

Throughout his career, Huang has been associated with prominent institutions, including the University of California and the University of Southern California. His work at these universities has allowed him to push the boundaries of scientific knowledge and innovation, facilitating advancements in the medical and biotechnological fields.

Collaborations

Huang has collaborated with esteemed colleagues, including fellow researchers Xudong Fu and Xiang Yin. Together, they have contributed to important discoveries and developments in their respective fields, showcasing the power of teamwork in the pursuit of innovative solutions.

Conclusion

Jing Huang's impressive track record as an inventor highlights his dedication to innovation and excellence. With 13 patents and ongoing research, he continues to pave the way for advancements in biotechnology that could revolutionize the treatment of various diseases and enhance production methodologies. Huang's journey serves as an inspiration to aspiring inventors and researchers alike.

Profile summary based on public USPTO records.